Mount Sinai researchers may have unlocked the key to better understanding the effect addictive drugs have on the human brain. Researchers have just published the new breakthrough study, “Design Logic of a Cannabinoid Receptor Signaling Network that Triggers Neurite Outgrowth,” in the latest issue of Science on May 16th, 2008.
“The research findings give us a new window into the brain, helping us to better understand the role addictive drugs have on the inner workings of brain cells ,” said Ravi Iyengar Ph.D., study author and Dorothy H. and Lewis Rosenstiel Professor and Chair, Department of Pharmacology and Systems Therapeutics at Mount Sinai School of Medicine. “This type of research provides may clues for targets within brain cells against which drugs that block addiction may be targeted.”
Mount Sinai researchers looked at the systems biology approach in order to study molecular networks underlying addiction. The findings start to unravel the complex interactions within brain cells, which are involved in processing signals from receptors in the brain that recognize the addictive drugs.
Researchers discovered that a drug that works through the cannabinoid 1 receptor recognizing the active ingredient of marijuana activates many different transcription factors, triggering the differentiation of neurons, causing permanent changes in a person’s brain. Another result of study was the discovery of a new role of the breast cancer gene BRCA 1 in neuronal differentiation and the effects of addictive drugs upon them.
Source: The Mount Sinai Hospital
Related stories:
Research reveals molecular fingerprint of cocaine addiction
The first large-scale analysis of proteins in the brains of monkeys addicted to cocaine reveals new information on how long-term cocaine use changes the amount and activity of various proteins affecting brain function.
Hunger hormone: Makes food more attractive
A new brain-imaging study by researchers at the Montreal Neurological Institute, McGill University reveals that ghrelin - a stomach hormone, acts on specific regions of the brain to enhance our response to food related cues and eating for pleasure. This study, published in the May 7 issue of
Cell Metabolism, is critical to advance understanding and treating obesity, a condition affecting millions world-wide.
Imaging study provides glimpse of alcohol's effect on brain
New brain imaging research published this week shows that, after consuming alcohol, social drinkers had decreased sensitivity in brain regions involved in detecting threats, and increased activity in brain regions involved in reward. The study, in the April 30 issue of
The Journal of Neuroscience, is the first human brain imaging study of alcohol’s effect on the response of neuronal circuits to threatening stimuli.
Mix of 2 pain-relief procedures can end chronic back and leg pain without drugs
Help is on the way for patients who have undergone back surgery but who continue to suffer from chronic pain in their backs and legs, thanks to a novel technology pioneered by two Chicago-area pain management specialists.
Researchers stumped by drug addiction paradox
From chocolate and caffeine to nicotine and cocaine, many of our most addictive foods and drugs come from plant toxins. Considering that plants originally developed these toxins to deter herbivorous predators, it’s ironic that humans and other mammals don’t merely tolerate the toxins, but can crave them and even develop dependencies on them.
Gene therapy reduces cocaine use in rats
Researchers at the U.S. Department of Energy's Brookhaven National Laboratory have shown that increasing the brain level of receptors for dopamine, a pleasure-related chemical, can reduce use of cocaine by 75 percent in rats trained to self-administer it. Earlier research by this team had similar findings for alcohol intake. Treatments that increase levels of these chemicals - dopamine D2 receptors -- may prove useful in treating addiction, according to the authors. The study will be published online April 16 and will appear in the July 2008 issue of
Synapse.
Mental illness and drug addiction may co-occur due to disturbance in part of the brain
Why do mental illness and drug addiction so often go together? New research reveals that this type of dual diagnosis may stem from a common cause: developmental changes in the amygdala, a walnut-shaped part of the brain linked to fear, anxiety and other emotions. A full report on why these “comorbid” disorders may develop appears in the December
Behavioral Neuroscience, published by the American Psychological Association (APA).
Decision-makers seek internal balance, not balanced alternatives
A researcher at the University of California, San Diego School of Medicine suggests that psychiatrists may need to approach the treatment of psychiatric patients from a new direction – by understanding that such individuals’ behavior and decision-making are based on an attempt to reach an inner equilibrium.